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Abstract
Background Quality of life measures going beyond health, like the ICECAP-A, are gaining importance in health technology 
assessment. The assessment of the monetary value of gains in this broader quality of life is needed to use these measurements 
in a cost-effectiveness framework.
Methods We applied the well-being valuation approach to calculate a first monetary value for capability well-being in 
comparison to health, derived by ICECAP-A and EQ-5D-5L, respectively. Data from an online survey administered in 
February 2018 to a representative sample of UK citizens aged 18–65 was used (N = 1512). To overcome the endogeneity 
of income, we applied an instrumental variable regression. Several alternative model specifications were calculated to test 
the robustness of the results.
Results The base case empirical estimate for the implied monetary value of a year in full capability well-being was £66,597. 
The estimate of the monetary value of a QALY, obtained from the same sample and using the same methodology amounted 
to £30,786, which compares well to previous estimates from the willingness to pay literature. Throughout the conducted 
robustness checks, the value of capability well-being was found to be between 1.7 and 2.6 times larger than the value of health.
Conclusion While the applied approach is not without limitations, the generated insights, especially concerning the rela-
tive magnitude of valuations, may be useful for decision-makers having to decide based on economic evaluations using the 
ICECAP-A measure or, to a lesser extent, other (capability) well-being outcome measures.
Keywords Capability approach · Economic evaluation · Value of health · Subjective well-being · Well-being valuation
JEL Classification I10 · I30
Introduction
Health economic evaluations are increasingly used in health 
care decision making. In countries like the UK and the 
Netherlands, specifically cost-utility analysis is a frequently 
applied tool to inform the allocation of scarce (health care) 
resources, with the aim of optimising population health [1]. 
In recent years it has been questioned whether health, meas-
ured for example with instruments such as EQ-5D, is the 
appropriate maximand in all contexts of health care delivery. 
Sometimes, the benefits of care interventions may not be 
limited to health alone, and the aim of interventions may 
not be to restore or improve health, but rather to maintain 
or increase the well-being of patients [2, 3]. The question 
of what we want to maximise appears especially relevant in 
the palliative and elderly care sectors, and in mental health 
and integrated social care [4, 5]. The interventions in those 
areas may range from pharmaceutical interventions to home 
care and, in the context of multi-morbidity, combinations of 
treatments.
As a consequence, several instruments have been put for-
ward, aiming to measure quality of life in a broader sense, 
which could be applied to broaden the evaluative space 
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of health economic evaluations [6]. In this context, some 
researchers focused on an operationalisation of Amartya 
Sen’s capability approach [7], which emphasises the impor-
tance of individuals’ ability to reach certain well-being states 
(capability) instead of being in these states (functioning). A 
prominent example is the ICEpop CAPability measure for 
adults (ICECAP-A), an instrument developed for assessing 
the capability well-being of the general adult population. 
The ICECAP-A measures capabilities in five dimensions 
with four levels each: (i) stability (ii) attachment (iii) auton-
omy (iv) achievement, and (v) enjoyment [8]. The measure 
was validated and tested in different contexts with promising 
results and continues to be validated further [9–14]. Moreo-
ver, it was shown that the ICECAP-A measures a broader 
construct and also comprises complementary information 
compared to common generic health utility measures like 
EQ-5D-3L and EQ-5D-5L [15, 16].
In the new Dutch pharmaco-economic guidelines specific 
attention is paid to broader outcome measures, in particular 
the ICECAP instruments [17]. This may not only increase 
their use in the context of economic evaluations of phar-
maceutical and other interventions, but also brings up the 
issue as to how the results of such broader economic evalua-
tions should be used in decision making. Indeed, the current 
(applications of) capability measures still raise important 
questions [18], including how results from economic evalu-
ations using capabilities, likely in the form of incremental 
cost-effectiveness ratios (ICERs), should be interpreted. Val-
uable in this context would be information on an appropriate 
threshold value for capabilities, analogous to the quality-
adjusted life-year (QALY) threshold for health gains. While 
the monetary value of a QALY has been extensively studied, 
primarily using willingness to pay [19, 20], research on the 
monetary value of capability well-being is still lacking.
This study aims to fill this gap, by estimating a first mon-
etary value of a year in full capability well-being, using the 
well-being valuation method to ICECAP-A index values in 
a representative sample of UK citizens aged 18–65. Using 
the same approach and sample, we furthermore provide esti-
mates of the same kind for the monetary value of a QALY 
based on EQ-5D-5L data, facilitating a first comparison of 
the societal valuations of these constructs.
Methods
Conceptual model
The well-being valuation approach uses observational data 
to assess the experienced average impact of a change in a 
good on individuals’ overall utility u, proxied by subjec-
tive well-being (SWB) or life satisfaction, and calculating 
the change in income necessary to maintain the same level 
of utility [21]. This obtained monetary valuation is also 
known as compensating surplus (CS). This regression-based 
approach circumvents the inherent drawbacks of willing-
ness to pay experiments by not directly asking individuals 
for a monetary value of a certain good [22, 23]. Applying 
the well-being valuation approach for estimating monetary 
values of capability well-being and health requires the fol-
lowing assumption about the relationship between health, 
capability and SWB: Individual’s overall utility u, as proxied 
by SWB, is a function of health or capability well-being Q. 
Imposing this type of relationship on capabilities is in con-
flict with the normative position that capabilities go not only 
beyond health but also beyond utility and SWB [24]. While 
we do acknowledge that there is some evidence based on 
individual-level data in favour of this competing interpreta-
tion [25], this is a necessary assumption due to the mechan-
ics of the well-being valuation approach.
Utility u is furthermore determined by income Y, and 
certain individual and socioeconomic characteristics sum-
marised in vector X. We followed a three-stage well-being 
valuation procedure, as previously formulated [21, 26]. 
The three steps include separately estimating the impact of 
income and the good to be valued on SWB (steps 1 and 2) 
and then calculating the compensating surplus (CS) accord-
ing to Eq. (2) (step 3):
Yʹ and Qʹ are the marginal effects of changes in income 
and health or capability on SWB, and Y0 represents a repre-
sentative level of population income.
Data and model specification
The data for the analysis originated from a cross-sectional 
survey of UK citizens, which was not specifically designed 
for this analysis and is, therefore, limited to individuals 
aged 18–65. Random sampling and survey administration 
were conducted by Survey Sampling International in Feb-
ruary 2018 using an online survey format. The sample was 
aimed to be representative regarding age, gender and level 
of education and consisted of 1512 individuals. The sur-
vey included inter alia questions about health, well-being, 
income, employment and marital status, religiosity and 
information about the health risk attitude of respondents (in 
the listed order) [27].
The impact of health H and capability well-being CW 
on SWB were estimated separately, due to their substan-
tial overlap and likely collinearity. While it has been dis-
cussed before that estimating the effect of health on SWB is 
prone to issues of endogeneity [28, 29], it was not possible 
(1)u(Q,Y ,X) = SWB(Q,Y ,X).
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to address this issue adequately due to the limitations of 
the used data. Applying a previously used instrument for 
health—average health per socioeconomic cell—was not 
feasible, possibly a result of the small sample size [30], 
SWBi was assessed using Cantril’s ladder, a one-dimensional 
life satisfaction instrument asking respondents to rate their 
life from worst possible to best possible life on a 0–10 scale 
[31]. The impact of health and capability well-being were 
estimated using ordinary least squares, assuming cardinality 
in the responses [32]:
Health of respondents Hi was measured via EQ-5D-5L 
utilities, applying the English EQ-5D-5L tariff estimated by 
Devlin et al. (2018) [33]. Capability well-being, CWi, was 
assessed via ICECAP-A index values [8, 34]. Estimates for 
income Yi were obtained by asking respondents to place their 
combined monthly household income before taxes into 12 
prespecified intervals. In a follow-up question, respondents 
were asked to indicate exact amount within these intervals. 
Missing exact income amounts were imputed based on the 
sample means of the income interval selected in the first 
step, if applicable. Xi contains age, gender, education, mari-
tal status, and employment status, which have been shown 
to influence SWB [35]. Following further guidance from 
the literature, we also controlled for religiosity, measured 
by asking for the importance of religion on a 7-point Lik-
ert-scale, and religious affiliation [36]. Information on the 
health risk attitude of individuals [27] was included to partly 
account for personality [37].
Income coefficient estimates in SWB regressions are 
likely endogenous due to reverse causality [38, 39], meas-
urement error or omitted variables like working hours, or 
time spent away from family [40]. Instrumental variable 
(IV) approaches have been used to overcome this problem 
[41, 42]. We, therefore, applied a two-stage least squares 
(2SLS) approach [43], testing different available candidate 
instruments. In the final analysis, we used whether a house-
hold currently holds home contents insurance (CI) as an 
instrument for income Y. The logarithmic transformation 
of income was used to account for its diminishing marginal 
return on SWB [44]. The 2SLS approach took the follow-
ing form:
To be a suitable instrument, CI must be sufficiently 
correlated with income. Possible channels could be that 




+ 3Xi + i,




+ 3Xi + i.




+ 3Xi + i,
(6)ln(Yi) = 0 + 1CIi + 2Xi + vi.
purchasing the insurance is more affordable if income is 
higher, or that higher income could lead to the household 
containing more valuable objects, which increases the 
likelihood of obtaining CI.
The instrument should furthermore only be correlated 
with SWB through income. However, this is generally not 
testable [43]. It is unlikely that the presence of contents 
insurance (directly) influences individuals’ SWB. The 
insurance effect of increased (financial) stability could be 
a possible channel. However, we found only a small and 
negative correlation between CI and the stability dimen-
sion of the ICECAP-A (r = − 0.15). Maintaining CI could 
relate to personality traits like risk aversion, which might 
influence SWB. Nevertheless, we were directly controlling 
for risk attitude, which is furthermore merely weakly cor-
related with CI (r = 0.14). Additionally, the obtained SWB 
values might not originate from the same individual, who 
decided about purchasing CI. Unfortunately, we had no 
information available to investigate this. Finally, CI could 
be indicative of possessing more valuable items or living 
in a nicer home, which does impact SWB [35]. However, 
we argue that these aspects are also, at least partly, medi-
ated through income.
Coefficient estimates from Eqs. (3) to (6) were used to 
calculate the compensating surplus (CS) for one QALY and 
one year in full capability well-being (YFC) according to the 
following equations:
where Y0 was set to the sample’s median yearly house-
hold income of £27,000, while ΔH and ΔCW represented 
incremental changes in health and capability well-being. 
It was necessary to impose incremental changes of H and 
CW since under the framework laid out in Eq. (2) the CS 
would be constrained at the pre-specified level of income 
[26]. The incremental approach mirrors contingent valu-
ation studies, where willingness to pay for small health 
changes are aggregated to a full QALY [19]. The size of the 
incremental change Δ was set to 0.1, corresponding to half 
a standard deviation, which was found to be a reasonable 
approximation of the minimally important clinical difference 
for health-related quality of life measurements [45].
Descriptive and regression analyses were performed 
using STATA 15.0 (Stata Corp. 2018. Stata Statistical Soft-
ware: Release 15. College Station, TX: Stata Corp LP). 
2SLS estimates were obtained using the ivreg2 package [46]. 
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Robustness checks
The robustness of the estimates was examined testing the 
following specifications: First, to gain insights into the rel-
evance of accounting for the endogeneity of income, the 
non-instrumented, standard OLS income estimate was used 
instead of the IV income estimate. Second, an income coef-
ficient estimate from a study based on much richer data was 
used. We linearly rescaled the dependent variable from 0–10 
to 1–7 interval to match the SWB measure used in the analy-
sis by Fujiwara [26], and applied his log-income coefficient 
estimate, as it was based on (random) lottery wins. Third, 
SWB was assessed via the multidimensional Satisfaction 
with Life Scale (SWLS) instead of Cantril’s ladder [47], 
with SWLS scores rescaled from 0 to 10 to facilitate com-
parison of coefficients. Fourth, the unweighted average of 
Cantril’s ladder and SWLS on a 0–10 scale were used as a 
compound SWB measure, as it was previously suggested 
that such a compound measure could be more robust than 
either of the measures on its own [48]. Fifth, instead of using 
the weighted population tariffs for scoring EQ-5D-5L and 
ICECAP-A values, we used the unweighted and rescaled 
(0–1) sum scores of these measures to test the sensitivity 
of the estimates to applying population tariffs, as both tar-
iffs were based on different valuation methods. In the sixth 
robustness check, the mapped EQ-5D-3L value set was used 
instead of the EQ-5D-5L value set, since the methodology 
applied for the latter has come under scrutiny [49]. In the 
seventh specification, Y0 was set to the mean yearly income 
of £37,843, instead of the median income of £27,000. In the 
last two robustness checks, ΔH and ΔCW were set to 0.05 
and 0.20, as the size of the increment may still be considered 
somewhat arbitrary.
Results
Estimates for income, health and capability 
well‑being
After excluding 139 observations with no income informa-
tion, and imputing income interval sample means for 358 
respondents who only reported their income interval, the 
analysis sample included 1373 individuals. There were no 
missing values in the remaining variables. This sample was 
comparable to the UK population aged 18–65 concerning 
most characteristics (Table 1). The reported average yearly 
gross income of £37,843 in the sample is lower than the UK 
average of £45,773 in 2018. The average ICECAP-A index 
is slightly lower than previously observed in a general pop-
ulation sample, which included individuals above 65 with 
generally lower capabilities [50].
Coefficients from the separate health and capability 
regressions as described in Eqs. (3) and (4) are shown 
in columns (I) and (II) of Table 2. Parameters estimates 
for EQ-5D-5L and ICECAP-A were positive and signifi-
cant, (2.665 and 6.234), meaning that health and capabil-
ity have the expected positive impact on SWB. The signs 
of the coefficients of most control variables corresponded 
to findings from the literature [35, 41]. Coefficient esti-
mates from the 2SLS IV regression are shown in column 
(III). Around a third of respondents (N = 516) reported that 
their household holds contents insurance. The log-income 
coefficient was 2.201. Control variables deviated slightly 
between the models, namely in a higher positive impact of 
being retired, a negative impact of education and no effect 
of marital status and unemployment.
Table 1  Characteristics of analysis sample and IV-sample
IV instrumental variable, HH household; Importance of religion 
measured on a 1 (low) to 7 (high) scale; HRAS health risk attitude 
scale ranging from 6 (risk loving) to 42 (risk averse)
Total sample IV-sample
Mean SD Mean SD
Cantril’s ladder 6.4 2.0 6.9 1.8
ICECAP-A 0.75 0.20 0.79 0.176
EQ-5D-5L 0.84 0.21 0.85 0.205
HH income in £ 37,843 56,729 45,200 78,838
Age 42.6 13.9 47.2 12.4
Female 51.8% 48.8%


















 Other religion 8.4% 7.0%
Importance of religion 2.8 2.0 2.8 2.1
HRAS 29.0 5.8 30.1 5.4
N 1373 1373
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Kleibergen-Paap rk Wald F statistic (21.832 with Stock-
Yogo critical 10% value 16.38) and Kleibergen-Paap rk 
LM statistic of (21.746, p < 0.001), indicated that the used 
instrument was not weak or underidentified. This was further 
substantiated by a significant coefficient (p < 0.001) of CI in 
the first stage regression (Appendix A). The characteristics 
of the IV sample were reasonably similar to the full sam-
ple (Table 1), with slightly higher levels of life satisfaction, 
capability well-being and income. Testing for the endogene-
ity of log income revealed that the variable should not have 
been treated as exogenous (p < 0.001).
Implied monetary values and results 
from robustness checks
The resulting monetary valuations of one QALY and one 
YFC were £30,786 and £66,597, respectively. The rela-
tive size of the monetary value of capability well-being 
compared to health was thereby estimated to be 2.2. Coeffi-
cients estimates and the corresponding monetary valuations 
for the conducted robustness checks are shown in Table 3. 
First, not instrumenting for income led to considerably 
larger monetary estimates of one QALY (£112,336) and 
one YFC (£193,305). Second, applying the income coef-
ficient from Fujiwara (2013), who used lottery wins, led to 
slightly higher monetary estimates compared to the base 
case. Third, using SWLS instead of Cantril’s ladder provided 
an almost identical monetary value for one YFC, while the 
value of one QALY was reduced to £20,988. Fourth, the 
use of the compound SWB score averaged out differences 
in coefficients and monetary valuations between the use of 
Cantril’s ladder and SWLS as SWB proxies. Fifth, employ-
ing sum scores of EQ-5D-5L and ICECAP-A resulted in 
slightly higher estimates of the value of one QALY and con-
versely, slightly lower estimates for one YFC. Applying the 
mapped EQ-5D-3L tariff reduced the monetary valuation 
Table 2  Results of OLS and IV 
regressions
Input parameters for Eqs. (7) and (8) are in bold
HRAS health risk attitude scale; Standard errors in parentheses; *p < 0.05, **p < 0.01, ***p < 0.001
(I) (II) (III)
Health Capability Income-IV
Log yearly income 0.495*** (0.065) 0.308*** (0.054) 2.201*** (0.638)
EQ-5D-5L − 2.665*** (0.305) 2.310*** (0.378)
ICECAP-A 6.234*** (0.243)
Age − 0.026 (0.029) − 0.006 (0.024) − 0.004 (0.037)
Age-squared 0.0003 (0.000) 0.0001 (0.000) 0.0001 (0.000)
Male − 0.011 (0.093) − 0.012 (0.075) − 0.068 (0.119)
Tertiary education 0.038 (0.094) − 0.085 (0.076) − 0.395* (0.199)
Divorced or widowed − 0.358* (0.168) 0.078 (0.132) 0.256 (0.304)
Never married − 0.536*** (0.121) − 0.033 (0.096) 0.202 (0.306)
Self-employed 0.100 (0.180) 0.117 (0.139) 0.451 (0.249)
Unemployed − 0.579* (0.231) − 0.275 (0.190) 0.661 (0.546)
Homemaker − 0.257 (0.169) − 0.028 (0.133) 0.387 (0.308)
Student − 0.357 (0.247) − 0.589** (0.226) − 0.084 (0.365)
Retired 0.537** (0.188) 0.115 (0.148) 0.864*** (0.253)
Unable to work − 0.514 (0.277) − 0.541** (0.197) 0.672 (0.534)
Atheist 0.245 (0.138) 0.182 (0.111) 0.268 (0.168)
Agnostic 0.097 (0.161) 0.095 (0.139) 0.038 (0.202)
Muslim − 0.462 (0.303) 0.013 (0.241) − 0.330 (0.307)
Other religion − 0.013 (0.172) 0.101 (0.145) − 0.095 (0.235)
Importance of religion 0.147*** (0.031) 0.097*** (0.025) 0.148*** (0.038)
HRAS 0.077*** (0.009) 0.033*** (0.007) 0.0687*** (0.011)
Constant − 2.858** (0.954) − 2.657*** (0.767) − 20.60** (6.687)
N 1373 1373 1373
Root MSE 1.662 1.345 2.021
R-squared 0.334 0.564 –
Kleibergen-Paap rk LM 21.55***
Kleibergen-Paap rk Wald F 21.63***
Test for endogeneity 10.65***
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of one QALY to £25,487. In the last three robustness tests, 
the income model had to be recalculated. As in the base 
case, the instrument passed under- and weak identification 
tests. Seventh, replacing median income by mean income 
increased the valuations to £43,149 and £93,343, respec-
tively. Altering the imposed incremental change of 0.1 index 
points to 0.05 reduced the monetary estimates slightly while 
imposing a 0.2 incremental change led to higher estimates 
compared to the base case. Throughout model alterations, 
the monetary equivalent value of one YFC exceeded that of 
one QALY by a factor of around two, with the robustness 
check utilising SWLS as SWB proxy as an outlier.
Discussion
Findings and related literature
Applying the well-being valuation method, we obtained a 
first estimate of the monetary value of ICECAP-A-derived 
capability well-being for the UK. We furthermore calcu-
lated the monetary value of health and were able to com-
pare the valuations of one QALY and one YFC directly. The 
empirical challenge inherent to the chosen approach is the 
endogeneity of income, which we tried to overcome using 
whether a household holds contents insurance as an instru-
ment for income. In the base case model specification, this 
yielded monetary valuations of £30,786 for one QALY and 
£66,597 for one YFC, corresponding to a ratio of 2.2. The 
conducted robustness checks produced relative magnitudes 
of these monetary valuations ranging from 1.7 to 2.6.
The calculated monetary value of a QALY lies within the 
range of estimates from the international willingness to pay 
literature, which on aggregate produced a trimmed mean and 
median estimate of £63,777 and £20,834 (in 2010 lb) [19]. 
UK specific estimates from Mason et al. (2009) and Baker 
et al. (2010) ranged from £24,219 to £70,896 and £16,000 
and £24,805 (in 2010 lb), respectively [51, 52]. In the only 
other application of the well-being valuation method for this 
purpose to date, the monetary value of one QALY in Aus-
tralia was estimated to be A$42,250 (£20,797) and A$67,022 
(£32,990) for short and long-term health gains using 2015 
prices [41]. The relative size of the reported monetary value 
of well-being (A$112,000 or £55,130) compared to one 
QALY was 1.7, not dissimilar to what we observed in our 
analysis.
Limitations
Although our results appear to have some face validity and 
are reasonably robust to model specifications, we need to 
acknowledge several limitations. On a more conceptual level, 
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an appropriate proxy for individuals’ utility. This may be a 
strong assumption, as SWB (or happiness) is not the only 
thing that people care about and preferences outside of SWB 
maximisation exist [21]. Nevertheless, based on the findings 
from subjective well-being research, as for example summa-
rised by Diener et al. (2018) [53], we argue that SWB mat-
ters enough to be able to use it as a proxy for welfare. At the 
same time, we must acknowledge that the validity and reli-
ability of SWB measures have been questioned before. These 
concerns were addressed in detail for example by Veenhoven 
(2012) [54]. What we can infer from our own analysis, is 
that the choice of SWB instrument does have an impact on 
the monetary estimates (Table 3), although observed differ-
ences were not substantial. The SWLS appears to capture a 
different part of SWB than Cantril’s ladder does. Differing 
results are likely a consequence of the SWLS containing two 
questions, which are more related to the past (“So far I have 
gotten the important things I want in life” and “If I could 
live my life over, I would change almost nothing”), while 
Cantril’s ladder only asks about SWB at present, which is 
more consistent with the present based well-being valua-
tion approach [47]. The well-being valuation literature so far 
does not provide guidance on the appropriateness of one- or 
multi-dimensional SWB measures, or the use of a composite 
of both. This should be examined in future research.
A further limitation is that we had to deviate from the 
intended three-stage well-being valuation approach in two 
ways [21, 26]: First, including control variables in order to 
prevent omitted variable bias conflicts with the idea of using 
total causal effects in calculating the monetary valuations as 
outlined before [21]. In the analysis by Fujiwara (2013), the 
difference in unemployment coefficients between a model 
without any covariates and a model controlling for several 
variables was minimal (− 0.441 and − 0.436). Removing 
all control variables from models (I) to (III) generated mon-
etary estimates for one QALY and one YFC of £33,914 and 
£63,156, respectively, close to the base case estimates. Sec-
ond, and potentially more problematic, we assumed exog-
eneity of both health and capability well-being due to the 
lack of suitable instruments. When health was instrumented 
in a previous analysis, the estimated impact of a change in 
health decreased slightly [30]. Assuming this would also 
hold in our context, our monetary valuations represent 
overestimations.
It is furthermore inherently difficult to demonstrate that 
the used income instrument (contents insurance) satisfies 
the exclusion restriction assumption. In the second robust-
ness check, we employed the log-income coefficient of 
Fujiwara (2013) for the UK, as an external reference point, 
after basing the analysis on the same SWB scale [26]. While 
not without limitations, his estimate, based on large scale 
panel data and exploiting random income shocks like lottery 
wins, can be considered as close to causal estimates as it 
gets when using non-experimental data. The reported log-
income coefficient of 1.103 is comparable to the estimate 
we obtained when repeating the analysis on the same SWB 
scale of 1.321. Monetary estimates increased by around 20% 
(Table 3). Judging from this comparison, it appears that our 
instrument performs reasonably well.
The extent to which our results are generalisable to the 
general UK population is unclear, as our sample did not 
include individuals aged 65 and above. Previous research 
suggests that functional limitations and social functioning, 
which are more related to the ICECAP-A, could be more 
relevant to the elderly than typical health dimensions, like 
morbidities or pain [55]. To test this, we included an interac-
tion term for the respective quality of life index and age to 
the base case models. We observed a positive and signifi-
cant coefficient of 0.031 (p = 0.042) for an interaction term 
between ICECAP-A and age, while the interaction coef-
ficient of EQ-5D-5L and age of 0.021 was not significant 
(p = 0.355). This indicates that omitting the elderly may have 
introduced a downward bias for the value of one YFC in 
comparison to the value of one QALY. Furthermore, due to 
relying on data from online survey panels, the individuals in 
the sample, in general, were quite healthy, with an average 
EQ-5D-5L index of 0.837 (SD 0.21). We do not know how 
the lack of sufficient observations at the lower end of the 
scale influenced our overall results. Lastly, we lacked infor-
mation on the household size of respondents, which pre-
cluded the use of equivalised household income, to facilitate 
the comparability across household compositions [40, 41].
Interpretation and implications of the results
While the calculated values for one QALY and one YFC 
varied across the conducted robustness checks, their ratio 
fluctuated at around two. As well-being measures were 
designed to capture quality of life beyond health, it is expli-
cable that the monetary value of well-being in general lies 
above the value of health alone. That this also holds for 
capability well-being could have been expected but had not 
yet been confirmed before.1 This information is relevant in 
the context of interpreting results of economic evaluations 
using broader outcome measures, which may be relevant in 
a range of interventions (from pharmaceuticals to palliative 
care) that have benefits not fully captured in conventional 
QALY measures.
The interpretation of the relative magnitude of the mon-
etary estimates of one QALY and one YFC deserve further 
attention, considering that the EQ-5D-5L and the ICECAP-A 
are anchored on two different scales. The former is anchored 
1 At the same time, it may be more difficult to achieve similarly sized 
increases on these broader measures.
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on a 0 to 1, dead to full health scale, with the possibility of 
health states below zero [33]. The latter ranges from 0 to 1 
for no capability to full capability, where death implies no 
capabilities, but no capabilities, in turn, does not necessar-
ily imply death [34, 56]. While it is plausible that on the 
higher end of the scale, capabilities go beyond health on an 
underlying overall quality of life continuum, it is less clear 
on the lower end of the scale, as having no capabilities could 
be equivalent to death, but also lower or higher in terms of 
overall quality of life. This may have implications for the 
comparability of the monetary valuations, as the imposed 
incremental change in health and capability of 0.1 may rep-
resent either a larger or smaller difference in the underlying 
utility. Future research could investigate these issues further, 
for instance, by focusing on the behaviour of SWB scores at 
very low levels of capabilities and health.
If capability well-being, as measured by the ICECAP-A, 
is included in future economic evaluations in areas where 
a focus on health is potentially too restrictive to capture 
all relevant benefits of an intervention, the here presented 
results could give a first indication about a cost-effectiveness 
threshold. In practice, ICERs calculated using ICECAP-A 
index values could be compared to the here estimated mon-
etary value of a YFC. Our estimates are especially relevant 
for countries that relate their threshold to the societal mon-
etary value of health or wellbeing gains, like the Nether-
lands [20]. In other countries, like the UK, thresholds are 
conceptually more related to the marginal cost-effectiveness 
of current spending [57]. Conceptually, this limits the direct 
applicability of our results in the UK, while it is noteworthy 
that obtaining opportunity cost based monetary estimates for 
capability well-being seems to be a challenging task.
Future research should aim for confirming our findings 
for the absolute and relative monetary valuation of capa-
bility well-being in general, either by employing alterna-
tive approaches, like willingness to pay or discrete choice 
experiments or by applying the well-being valuation method 
to other, preferably richer data sets. Prerequisite for the lat-
ter should be the availability of potential instruments for 
income. On a different note, while there are first applica-
tions, more conceptual and theoretical work is needed 
about whether, when and how capability well-being should 
be included in health economic evaluations [58]. One open 
question for example is, whether full capability or a suf-
ficient level of capability, which was established recently, 
should be considered as the objective of interventions [59]. 
Nevertheless, and to conclude, the results of our analysis 
may be useful as a first estimate of a threshold value for a 
YFC that can be used when making decisions based on eco-
nomic evaluations using the ICECAP-A, or to a lesser extent, 
other (capability) well-being outcome measures.
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